Atlas Trials

Delcath Systems Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Delcath Systems Inc.

RecordFirmDate
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease (NCT06875128)Delcath Systems Inc.2026-01-29
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease (NCT06607458)Delcath Systems Inc.2025-08-05
An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma (NCT05022901)Delcath Systems Inc.2022-06-10
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma (NCT03086993)Delcath Systems Inc.2018-04-10

Track Delcath Systems Inc. automatically

Every clearance here is in the API, with alerts when new ones post.